Wrap Text
Rights issue finalisation announcement
Mediclinic International Limited
Incorporated in the Republic of South Africa
(Registration number 1983/010725/06)
JSE share code: MDC
NSX share code: MCI
ISIN: ZAE000074142
(“Mediclinic”)
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES,
AUSTRALIA, CANADA, JAPAN, HONG KONG OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD BE UNLAWFUL. THIS
ANNOUNCEMENT DOES NOT CONSTITUTE OR FORM AN OFFER OF SECURITIES IN THE UNITED STATES OR ANY OTHER
JURISDICTION.
RIGHTS ISSUE FINALISATION ANNOUNCEMENT
Mediclinic shareholders are referred to the declaration announcement released on the Stock Exchange News Service on
21 July 2015, in the South African press on 22 July 2015 and in the Namibian press on 23 July 2015, relating to a fully
underwritten, renounceable rights issue to qualifying Mediclinic shareholders to raise an aggregate amount of R10 billion
(“Rights Issue”).
All conditions precedent to the Rights Issue have now been fulfilled and the Rights Issue will proceed on the terms and in
accordance with the timetable as set out in the declaration announcement.
The Rights Issue will consist of an offer of 111 111 111 new Mediclinic shares in the ratio of 12.80145 new Mediclinic shares
for every 100 Mediclinic shares held on the record date of the Rights Issue, being Friday, 7 August 2015, at an issue price of
R90.00 per Mediclinic share.
Stellenbosch
24 July 2015
JSE sponsor
Rand Merchant Bank (A division of FirstRand Bank Limited)
NSX sponsor
Simonis Storm Securities (Proprietary) Limited
Neither this announcement nor the Rights Issue constitutes or is intended to constitute an offer to the public in South Africa in terms of the
South African Companies Act 71 of 2008 (as amended).
This document does not constitute or form part of any offer or solicitation to purchase or subscribe for securities in the United States. The
rights offer described herein has not been and will not be registered under the U.S. Securities Act of 1933, as amended (“U.S. Securities
Act”), or under any relevant securities laws of any state or other jurisdiction of the United States. The securities described herein (the
“Securities”) may not be offered, sold, taken up, resold, renounced, exercised, pledged, transferred or delivered, directly or indirectly, in or
into the United States at any time except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of
the U.S. Securities Act and applicable state and other securities laws of the United States. The Securities may be offered, sold, taken up,
resold, renounced, exercised, pledged, transferred or delivered, by persons outside the United States in accordance with Regulation S
under the U.S. Securities Act. There will be no public offering of the Securities in the United States.
In member states of the European Economic Area (“EEA”) which have implemented the Prospectus Directive (each, a “Relevant Member
State”), this announcement and any offer if made subsequently is directed exclusively at persons who are “qualified investors” within the
meaning of the Prospectus Directive (“Qualified Investors”). For these purposes, the expression “Prospectus Directive” means Directive
2003/71/EC (and amendments thereto, including Directive 2010/73/EU, to the extent implemented in a Relevant Member State), and
includes any relevant implementing measure in the Relevant Member State.
In the United Kingdom this announcement is only being distributed to, and is only directed at, and any investment or investment activity to
which this announcement relates is available only to, and will be engaged in only with, Qualified Investors who are (i) investment
professionals falling with Article 19(5) of the UK Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the “Order”);
or (ii) high net worth entities falling within Article 49(2)(a) to (d) of the Order, (all such persons together being referred to as “relevant
persons”). Persons who are not relevant persons should not take any action on the basis of this announcement and should not act or rely
on it.
Date: 24/07/2015 08:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
Sharenet Sites 
